InfuSystem Holdings, Inc. (INFU)
Market Cap | 138.21M |
Revenue (ttm) | 127.41M |
Net Income (ttm) | 84,000 |
Shares Out | 21.30M |
EPS (ttm) | 0.01 |
PE Ratio | 644.00 |
Forward PE | 28.27 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 29,742 |
Open | 6.50 |
Previous Close | 6.44 |
Day's Range | 6.38 - 6.56 |
52-Week Range | 6.25 - 11.44 |
Beta | 1.29 |
Analysts | n/a |
Price Target | n/a |
Earnings Date | May 9, 2024 |
About INFU
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pol... [Read more]
Financial Performance
In 2023, INFU's revenue was $125.79 million, an increase of 14.44% compared to the previous year's $109.91 million. Earnings were $872,000, an increase of 4744.44%.
Financial StatementsNews
InfuSystem Reports First Quarter 2024 Financial Results
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Reports First Quarter 2024 Financial Results.
InfuSystem to Report First Quarter 2024 Financial Results on May 9, 2024
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Report First Quarter 2024 Financial Results on May 9, 2024.
InfuSystem Receives Notice from NYSE American Regarding Late Filing of Annual Report on Form 10-K
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Receives Notice from NYSE American Regarding Late Filing of Annual Report on Form 10-K.
InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2023
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2023.
InfuSystem to Report Fourth Quarter and Full Year 2023 Financial Results on March 14, 2024
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Report Fourth Quarter and Full Year 2023 Financial Results on March 14, 2024.
InfuSystem to Present at Sidoti Small-Cap Virtual Conference on December 6, 2023
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Present at Sidoti Small-Cap Virtual Conference on December 6, 2023.
InfuSystem to Participate at 14th Annual Craig-Hallum Alpha Select Conference on November 16, 2023
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Participate at 14th Annual Craig-Hallum Alpha Select Conference on November 16, 2023.
InfuSystem Reports Third Quarter 2023 Financial Results
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Reports Third Quarter 2023 Financial Results.
InfuSystem to Report Third Quarter 2023 Financial Results on November 7, 2023
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Report Third Quarter 2023 Financial Results on November 7, 2023.
Dignitana announces a sales and marketing partnership with InfuSystem to provide scalp cooling systems in the United States
LUND, Sweden , Oct. 4, 2023 /PRNewswire/ -- Scalp cooling innovator Dignitana AB announces today a sales and marketing partnership with InfuSystem Holdings, Inc., a leading health care service provi...
InfuSystem to Participate in Lake Street's 7th Annual Best Ideas Growth (BIG7) Conference September 14, 2023
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Participate in Lake Street's 7th Annual Best Ideas Growth (BIG7) Conference September 14, 2023.
InfuSystem Reports Second Quarter 2023 Financial Results
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Reports Second Quarter 2023 Financial Results.
InfuSystem to Report Second Quarter 2023 Financial Results on August 3, 2023
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Report Second Quarter 2023 Financial Results on August 3, 2023.
InfuSystem Set to Join Russell 3000® Index
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Set to Join Russell 3000® Index.
InfuSystem to Present at Sidoti Micro-Cap Virtual Conference on May 11, 2023
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Present at Sidoti Micro-Cap Virtual Conference on May 11, 2023.
InfuSystem Reports First Quarter 2023 Financial Results
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Reports First Quarter 2023 Financial Results.
InfuSystem to Report First Quarter 2023 Financial Results on May 4, 2023
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Report First Quarter 2023 Financial Results on May 4, 2023.
InfuSystem Announces Distribution Agreement with Genadyne for Negative Pressure Wound Therapy Systems
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Announces Distribution Agreement with Genadyne for Negative Pressure Wound Therapy Systems.
InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2022
InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufactur...
InfuSystem to Report Fourth Quarter and Full Year 2022 Financial Results on March 15, 2023
ROCHESTER HILLS, Mich.
InfuSystem to Participate at 13th Annual Craig-Hallum Alpha Select Conference on November 17, 2022
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient car...
InfuSystem Reports Third Quarter 2022 Financial Results
ROCHESTER HILLS, Mich.
InfuSystem and Sanara MedTech Announce Wound Therapy Partnership
ROCHESTER HILLS, Mich.
InfuSystem to Report Third Quarter 2022 Financial Results on November 8, 2022
ROCHESTER HILLS, Mich.
InfuSystem Appoints R. Rimmy Malhotra to the Board of Directors
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Appoints R. Rimmy Malhotra to the Board of Directors